High Tower Advisors, LLC Entera Bio Ltd. Transaction History
High Tower Advisors, LLC
- $84.5 Billion
- Q3 2025
A detailed history of High Tower Advisors, LLC transactions in Entera Bio Ltd. stock. As of the latest transaction made, High Tower Advisors, LLC holds 18,140 shares of ENTX stock, worth $56,959. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,140
Previous 67,544
73.14%
Holding current value
$56,959
Previous $128,000
73.44%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ENTX
# of Institutions
22Shares Held
10.2MCall Options Held
0Put Options Held
0-
Knoll Capital Management, LLC Miami, FL5.88MShares$18.5 Million7.6% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.7MShares$8.47 Million0.01% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY605KShares$1.9 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT356KShares$1.12 Million0.09% of portfolio
-
Northern Trust Corp Chicago, IL201KShares$630,3390.0% of portfolio
About Entera Bio Ltd.
- Ticker ENTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,809,900
- Market Cap $90.5M
- Description
- Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...